Literature DB >> 10537076

Identification of a new ligand binding domain in the alpha1 subunit of the inhibitory glycine receptor.

B Vafa1, T M Lewis, A M Cunningham, P Jacques, J W Lynch, P R Schofield.   

Abstract

Four discontinuous extracellular sequence domains have been proposed to form the ligand binding sites of the ligand-gated ion channel receptor superfamily. In this study, we investigated the role of 12 contiguous residues of the inhibitory glycine receptor that define the proposed "loop A" ligand binding domain. Using the techniques of site-directed mutagenesis and patch-clamp electrophysiology, four of the 12 residues were shown to have impaired ligand binding. Three mutants, 193A, A101H, and N102A, resulted in significant (17-44-fold) increases in the agonist EC50 values as compared with the wild-type glycine receptor, whereas Hill coefficients, ImaX values, and antagonist affinity remained largely unaffected. Consideration of receptor efficacy values indicates that these residues are involved in ligand binding rather than channel activation. A fourth mutant, W94A, failed to give rise to any glycine-activated currents, although cell-surface expression was observed, suggesting that this residue may also be involved in agonist binding. These data provide the most extensive characterization of the loop A ligand binding domain available to date and define two new residue locations, Ile93 and Asn102, as contributing to the four-loop model of ligand binding.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10537076

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

1.  A cation-π interaction at a phenylalanine residue in the glycine receptor binding site is conserved for different agonists.

Authors:  Stephan A Pless; Ariele P Hanek; Kerry L Price; Joseph W Lynch; Henry A Lester; Dennis A Dougherty; Sarah C R Lummis
Journal:  Mol Pharmacol       Date:  2011-01-25       Impact factor: 4.436

2.  Hereditary hyperekplexia caused by novel mutations of GLRA1 in Turkish families.

Authors:  Sandra L Gilbert; Fatih Ozdag; Umit H Ulas; William B Dobyns; Bruce T Lahn
Journal:  Mol Diagn       Date:  2004

3.  Endogenous Voltage Potentials and the Microenvironment: Bioelectric Signals that Reveal, Induce and Normalize Cancer.

Authors:  Brook Chernet; Michael Levin
Journal:  J Clin Exp Oncol       Date:  2013

4.  An improved ivermectin-activated chloride channel receptor for inhibiting electrical activity in defined neuronal populations.

Authors:  Timothy Lynagh; Joseph W Lynch
Journal:  J Biol Chem       Date:  2010-03-22       Impact factor: 5.157

5.  Aplysia cys-loop glutamate-gated chloride channels reveal convergent evolution of ligand specificity.

Authors:  JacSue Kehoe; Svetlana Buldakova; Francine Acher; Joseph Dent; Piotr Bregestovski; Jonathan Bradley
Journal:  J Mol Evol       Date:  2009-06-25       Impact factor: 2.395

6.  Genetic and functional analyses demonstrate a role for abnormal glycinergic signaling in autism.

Authors:  M Pilorge; C Fassier; H Le Corronc; A Potey; J Bai; S De Gois; E Delaby; B Assouline; V Guinchat; F Devillard; R Delorme; G Nygren; M Råstam; J C Meier; S Otani; H Cheval; V M James; M Topf; T N Dear; C Gillberg; M Leboyer; B Giros; S Gautron; J Hazan; R J Harvey; P Legendre; C Betancur
Journal:  Mol Psychiatry       Date:  2015-09-15       Impact factor: 15.992

7.  A cation-pi interaction in the binding site of the glycine receptor is mediated by a phenylalanine residue.

Authors:  Stephan A Pless; Kat S Millen; Ariele P Hanek; Joseph W Lynch; Henry A Lester; Sarah C R Lummis; Dennis A Dougherty
Journal:  J Neurosci       Date:  2008-10-22       Impact factor: 6.167

8.  Transmembrane voltage potential is an essential cellular parameter for the detection and control of tumor development in a Xenopus model.

Authors:  Brook T Chernet; Michael Levin
Journal:  Dis Model Mech       Date:  2013-02-01       Impact factor: 5.758

9.  Murine startle mutant Nmf11 affects the structural stability of the glycine receptor and increases deactivation.

Authors:  Megan E Wilkins; Alex Caley; Marc C Gielen; Robert J Harvey; Trevor G Smart
Journal:  J Physiol       Date:  2016-05-10       Impact factor: 5.182

10.  A Recombinant Human Pluripotent Stem Cell Line Stably Expressing Halide-Sensitive YFP-I152L for GABAAR and GlyR-Targeted High-Throughput Drug Screening and Toxicity Testing.

Authors:  Katharina Kuenzel; Oliver Friedrich; Daniel F Gilbert
Journal:  Front Mol Neurosci       Date:  2016-06-28       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.